GenSight Biologics S.A. (EPA:SIGHT)
France
· Delayed Price · Currency is EUR 0.0814
0.00 (0.00%)
Apr 28, 2026, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €19.09 million as of April 28, 2026. Its market cap has decreased by -38.86% in one year.
Market Cap
19.09M
Enterprise Value
29.53M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 19.09M, a decrease of -92.43%. That is a compound annual growth rate of -23.17%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advicenne | 17.88M |
| Aelis Farma | 17.26M |
| Aton | 17.06M |
| genOway Société anonyme | 23.05M |
| Poxel | 14.40M |
| NFL Biosciences | 13.18M |
| Nicox | 35.60M |
| Plant Advanced Technologies | 7.80M |